Skip to content

Radial Extracorporeal Shock Wave Therapy (rESWT) Treatment of Subacromial Shoulder Pain

Treatment of Subacromial Shoulder Pain

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01441830
Enrollment
150
Registered
2011-09-28
Start date
2011-09-30
Completion date
Unknown
Last updated
2014-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Impingement Syndrome, Subacromial Shoulder Pain

Keywords

shoulder, subacromial, impingement, tendinopathy, rESWT, shock wave, ESWT, RSWT

Brief summary

The purpose of this study is to determine whether rESWT (radial extracorporeal shock wave therapy) combined with supervised exercises will improve function and reduce pain in subacromial shoulder pain compared with supervised exercises alone.

Interventions

The shockwave treatment will be administered once a week for four weeks on one to three specific points (supraspinatus, infraspinatus or subscapular tendon)and with a pressure between 1,5-3 Bar

Sponsors

Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Dysfunction or pain on abduction * Pain on one of two isometric tests (abduction or external rotation) * Positive Hawkins sign * Normal passive glenohumeral range of motion

Exclusion criteria

* Previous surgery on affected shoulder * Instability * Total rupture of the rotator cuff (evaluated clinically or by US) * Clinical signs of a cervical syndrome * Infection in the area *

Design outcomes

Primary

MeasureTime frame
Shoulder Pain and Disability Index (SPADI)24 weeks

Secondary

MeasureTime frame
Health-related quality of life (Eq-5d)24 weeks and 1 year
Return to work6 weeks, 12 weeks, 24 weeks and 1 year
Pain and function measured on a 11 point Likert type scale6 weeks, 12 weeks, 24 weeks and 1 year

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026